Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
US8153693B2 · kind B2 · utility
20Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 23, 2008 |
| Grant date | Apr 10, 2012 |
| Priority date | — |
| Expiry date | Dec 23, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to amino-salicylic-aminophenyl compounds for use in the treatment of the inflammatory component of celiac disease. These compounds act by blocking the cytokines released in celiac disease and are specifically useful in the treatment of refractory cases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.